FDA-cleared profile

Preview Shoulder

Genesis Software Innovations · CT/CTA · FDA-cleared (510(k))

Preoperative shoulder-arthroplasty planning from adult CT DICOM images, including three-dimensional anatomy and implant-placement planning; it does not diagnose or recommend a surgical procedure.

Clinical role
Three-dimensional preoperative shoulder reconstruction and implant-placement planning.
Images and patients
CT/CTA · Shoulder
Key limitation
The software does not diagnose a condition or recommend a surgical procedure; the surgeon remains responsible for the plan and implant selection.

Overview status: Field-derived fact summary This section is assembled from the sourced field records below; it is not a source-reviewed editorial overview.

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • Imaging and anatomyCT/CTA · Shoulder
  • Workflow roleThree-dimensional preoperative shoulder reconstruction and implant-placement planning.
  • Required inputAdult shoulder CT DICOM images meeting the labeled protocol and quality requirements.
  • Output and human actionThree-dimensional anatomy, implant-placement planning information, and a clinician-reviewable report.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Preoperative shoulder-arthroplasty planning from adult CT DICOM images, including three-dimensional anatomy and implant-placement planning; it does not diagnose or recommend a surgical procedure.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Three-dimensional preoperative shoulder reconstruction and implant-placement planning.
  • Exact FDA submission
  • Checked 2026-09-08
Required input
Adult shoulder CT DICOM images meeting the labeled protocol and quality requirements.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
Three-dimensional anatomy, implant-placement planning information, and a clinician-reviewable report.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Preoperative orthopaedic planning environments.
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Orthopaedic surgeons planning shoulder arthroplasty.
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
The software does not diagnose a condition or recommend a surgical procedure; the surgeon remains responsible for the plan and implant selection.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
The exact FDA document reports software verification and validation testing: the software was verified via code reviews and automated and manual testing; measurement capabilities were validated as significantly equivalent to a benchmark tool, Osirix MD (K101342); all validation testing was performed on a fully configured system using anonymized patient shoulder CT images; and all user features were validated by surgeons. Clinical testing was not necessary to demonstrate substantial equivalence. Results are as reported in the FDA submission, not independent validation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Software Verification and Validation testing was performed on the Preview Shoulder," … "The software has been verified via code reviews and automated and manual testing.". Read from the exact FDA decision document on 2026-11-14.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA document reports software verification and validation testing: the software was verified via code reviews and automated and manual testing; measurement capabilities were validated as significantly equivalent to a benchmark tool, Osirix MD (K101342); all validation testing was performed on a fully configured system using anonymized patient shoulder CT images; and all user features were validated by surgeons. Clinical testing was not necessary to demonstrate substantial equivalence. Results are as reported in the FDA submission, not independent validation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Software Verification and Validation testing was performed on the Preview Shoulder," … "The software has been verified via code reviews and automated and manual testing.". Read from the exact FDA decision document on 2026-11-14.

Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K240172. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Adult shoulder CT DICOM images meeting the labeled protocol and quality requirements.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K240172: Preview Shoulder

  2. Routing

    Source context, not route validation: The cleared software imports CT DICOM data and produces planning outputs; current PACS connectivity and hosting topology require vendor confirmation.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K240172: Preview Shoulder

  3. AI processing

    Source context, not route validation: The exact FDA package describes Preview Shoulder as software installed and started from the user's computer, a personal computer or workstation running Windows or MacOS. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Personal Computer or Personal Computer or N/A Workstation Workstation Operating Windows or MacOS Windows or MacOS N/A" … "The software is installed The software is installed N/A Availability and started from the and started from the user’s computer. user’s computer.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K240172: Preview Shoulder

  4. Returned objects

    Source context, not route validation: Three-dimensional anatomy, implant-placement planning information, and a clinician-reviewable report.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K240172: Preview Shoulder

  5. Viewer/worklist/report

    Unresolved route: Three-dimensional anatomy, implant-placement planning information, and a clinician-reviewable report.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K240172: Preview Shoulder

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes Preview Shoulder as software installed and started from the user's computer, a personal computer or workstation running Windows or MacOS. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Personal Computer or Personal Computer or N/A Workstation Workstation Operating Windows or MacOS Windows or MacOS N/A" … "The software is installed The software is installed N/A Availability and started from the and started from the user’s computer. user’s computer.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The cleared software imports CT DICOM data and produces planning outputs; current PACS connectivity and hosting topology require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-09-08

Current product-family workflow context

Genesis Innovation Group describes the Preview Shoulder family as CT-based, three-dimensional preoperative planning software for shoulder arthroplasty.

product family · checked 2026-09-08

Confirm exact-release availability, interfaces, hosting, security, support, and commercial terms during procurement.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K240172
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Shoulder
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-04-04
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-08Last searched
19Fields reviewed
9Source classes checked
0Awaiting review PubMed leads
0Awaiting review trial leads
0Unreviewed FDA recall leads

Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact FDA scope controls clinical claims. ACR and official vendor material provide bounded catalog or product-family context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, vendor press release, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K240172 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-08 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 2 history items

Source ledger

  1. FDA K240172: Preview Shoulder

    U.S. Food and Drug Administration - Published 2024-04-04 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. openFDA exact recall query for K240172

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

  7. Preview Shoulder software FDA clearance announcement

    Genesis Innovation Group - Accessed 2026-09-08

    Scope: productFamily, clinicalWorkflow

Research history

  1. K240172 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

Alternatives

Related tools to compare

FDA-cleared K210556

Preview Shoulder

Genesis Software Innovations

Authorized purpose: Tool for orthopedic surgeons to develop pre-operative shoulder arthroplasty plans from patient CT imaging.

Modality
CT/CTA
Anatomy
Shoulder
Decision
2021-04-21
FDA-cleared K213779

Customize

3D-Side SA

Authorized purpose: Customize supports adult shoulder arthroplasty planning with CT segmentation, three-dimensional models, implant positioning and sizing, case management, and physician approval; it is not for diagnosis, spine surgery, or implant and instrument design.

Modality
CT/CTA
Anatomy
Shoulder
Decision
2022-03-16
FDA-cleared K253560

Enhanced Boundary for PCCT

Ge Medical Systems, LLC

Authorized purpose: Enhanced Boundary for PCCT is a deep-learning CT processing function for improved soft-tissue delineation in routine head examinations with or without contrast.

Modality
CT/CTA
Anatomy
Head
Decision
2026-06-24
FDA-cleared K253649

Spectral CT Verida Family

Philips Medical Systems Technologies, Ltd.

Authorized purpose: Spectral CT Verida Family supports the labeled spectral CT acquisition, reconstruction, material-map, and professional-interpretation workflow; exact models, protocols, and derived outputs remain submission-specific.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-27

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history